4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0001628280-26-015758
Chief Commercial Officer sold 419 shares at $431.94 ($180,983)
- Chief Commercial Officer acquired 3,989 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Huntsman Carole Chief Commercial Officer | 2026-03-04 | Grant or award | +3,989 | 13,111 | D | ||
| Huntsman Carole Chief Commercial Officer | 2026-03-06 | Sale | −419 | $431.94 | $180,983 | 12,692 | D |
| Derivatives | |||||||
| Huntsman Carole Chief Commercial Officer | 2026-03-04 | Grant or award · Stock Option (Right to Buy) | +4,986 | 4,986 | D | ||
| Open-market sales · 419 sh · avg $431.94 · $180,983 | |||||||
Loading xslF345X05/wk-form4_1772838950.xml…